Discuss with your healthcare provider the option of lowering the dose, slowing the titration schedule, or switching to a different treatment
"The Noom Microdose GLP-1Rx Program was designed to address this issue by introducing GLP-1s gradually and sustaining them at a microdose level, as part of a larger holistic behavior change platform, which we call our GLP-1 Companion
Apperloo, E
Clinically Proven Support for GLP-1 Users In a 2025 double-blind, placebo-controlled study over 6 weeks in New Jersey, SymptoGuard showed significant improvements for GLP-1 users compared to placebo
(Industry coverage of Eli Lilly's December 2025 TRIUMPH-4 topline announcement, including the 28.7% body weight loss figure on 12mg, the 2.1% placebo figure, and the schedule for remaining 2026 readouts.) Eli Lilly and Company
Hims & Hers Pulls Back GLP-1 Weight-Loss Pill Shortly afterward, Hims & Hers Health abruptly abandoned its plan to launch a compounded version oral weight-loss pill priced as low as $49/month, backing off within days amid regulatory pressure and industry backlash
